<DOC>
	<DOCNO>NCT00496509</DOCNO>
	<brief_summary>A Phase I , Open-Label Study To Assess The Effect ZD6474 ( ZACTIMA ) On Vascular Permeability In Patients Advanced Colorectal Cancer Liver Metastases .</brief_summary>
	<brief_title>Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Histologically confirm metastatic colorectal adenocarcinoma ( stage IV ) least 1 measurable hepatic lesion 20 mm MRI standard therapy available . WHO Performance status 0 2 . Life expectancy least 12 week Brain metastasis spinal cord compression , unless treat least 4 week entry stable without steroid treatment 10 day great . Last dose prior chemotherapy must discontinue least 4 week start study treatment . Last dose radiotherapy receive within 4 week start study treatment exclude palliative radiotherapy . Prior treatment VEGFR TKIs Serum bilirubin . 1.5 x upper limit reference range . Serum creatinine &gt; 1.5 x ULRR Creatinine clearance ( determine Cockcroft Gault method ) less equal 50 mL/min . ALT AST &gt; 5 x ULRR ALP &gt; 5 x ULRR Evidence severe uncontrolled systemic disease concurrent condition investigator opinion make undesirable patient participate study would jeopardize compliance protocol . Any unresolved toxicity great CTCAE Grade 2 previous anticancer therapy . Significant cardiovascular event within 3 month entry , presence cardiac disease opinion investigator increase risk ventricular arrhythmia . History arrhythmia symptomatic require treatment ( CTCAE grade 3 ) asymptomatic sustain ventricular tachycardia . Atrial fibrillation , control medication exclude . Congenital long QT syndrome 1st degree relative sudden unexplained death 40 year age . Presence Left Bundle Branch Block . QTc Bazett 's correction unmeasurable great equal 480 msec great screen ECG . Potassium &lt; 4.0 mmol/L despite supplementation , serum calcium ( ionize adjust albumin ) , magnesium normal range despite supplementation . Women pregnant breast feeding . Any concomitant medication may cause QTc prolongation induce induce Torsades de Pointes induce CTP3A4 function . Hypotension control medical therapy . Participation clinical study investigational pharmaceutical agent within 30 day prior commence study treatment . Major surgery within 4 week incompletely heal surgical incision . Previous current malignancy histology within last 5 year , exception situ carcinoma cervix adequately treat basal cell Squamous cell carcinoma skin . Any contraindication MRI scan . Involvement plan conduct study . Previous enrollment randomization treatment present study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>ZD6474</keyword>
	<keyword>Colorectal Cancer</keyword>
	<keyword>Liver Metastases</keyword>
	<keyword>Biomarkers</keyword>
</DOC>